Table 2.

Proposed therapies for anti-NMDAR encephalitis.

First-line therapies (if tumor is present, begin after removal)	Second-line therapies (if disease is refractory after 10 days)
IVIG 0.4 g/kg for 5 days and methylprednisolone 30 mg/kg daily for 5 days or plasma exchange daily for six cycles	Rituximab 375 mg/m2 weekly for 4 weeks and cyclophosphamide 750 mg/m2 monthly (duration is based on clinical improvement)